Florey researchers discover mRNA's Alzheimer's disease targeting potential.

Apr 01, 2024

∙ Paid

Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias.

To date, mRNA has been predominantly used for vaccines, including those used to fight COVID-19.

New research published today in Brain Communications establishes The Florey as a key…

Keep reading with a 7-day free trial

Subscribe to MENCARI - Delivered fearless reporting to you to keep reading this post and get 7 days of free access to the full post archives.